Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Wegovy® (semaglutide 2.4mg) is a once-weekly injectable treatment indicated for chronic weight management in adults and adolescents (aged 12 and above) living with obesity (BMI ≥30 kg/m²), or who are overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia1. It is used alongside a reduced-calorie diet and increased physical activity, supporting Singapore's efforts to improve population health.
The treatment works by addressing one of the underlying biological drivers of obesity. Wegovy® (semaglutide 2.4mg) is a GLP-1 receptor agonist with 94% similarity to the body's natural GLP-1 hormone. It activates receptors involved in appetite regulation, helping individuals feel full sooner and reduce food intake1. This mechanism supports weight loss when combined with sustainable lifestyle changes.
The availability of Wegovy® (semaglutide 2.4mg) comes as obesity continues to pose a significant health burden in Singapore. An estimated 600,000 adults are currently living with obesity2-4, a condition associated with more than 200 health complications5. Despite its prevalence and medical complexity, obesity remains heavily stigmatised—often misunderstood as merely the result of poor personal choices. Individuals living with obesity frequently face discrimination and mental health challenges which further isolate them. This misplaced blame, rather than targeting the disease itself, creates barriers to and slows the advancement of effective obesity treatment. Recognised by World Health Organization as a chronic disease6, obesity requires compassionate evidence-based care. The launch of Wegovy® (semaglutide 2.4mg) in Singapore provides a new treatment option for weight management available through private prescription.
Dr Abel Soh, Abel Soh Diabetes, Thyroid and Endocrine Clinic and Chairperson for Endocrine and Metabolic Society of Singapore (EMSS) stated, 'Obesity is not simply the result of lifestyle choices — it is a medically recognised chronic disease influenced by a complex interplay of genetics, hormones, and environment. In my clinical practice, I see firsthand how many individuals blame themselves when in fact, their biology is often working against them. It's time we shift the conversation from blame to support in the management of individuals with obesity'
Lifestyle factors in Singapore further contribute to the challenge. In Singapore's demanding work culture—where full-time employees work an average of 44.6 hours per week7, with time constraints and fatigue frequently cited as barriers to maintaining regular physical activity. These circumstances underscore the importance of comprehensive treatment strategies that facilitate the adoption of healthier lifestyles, including increased physical activity and a reduced-calorie diet, as integral components of long-term weight management.
Mr Vincent Siow, General Manager, Novo Nordisk Singapore, said 'With treatments like Wegovy® (semaglutide 2.4mg) now available in Singapore, we have an opportunity to provide healthcare professionals with more evidence-based options to support their patients in regaining control of their health and improving long-term outcomes.'
References:
1. Wegovy Singapore Prescribing Information, February 2025
2. Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508.
3. World Obesity. Retrieved from https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity
4. World Obesity. Retrieved from https://data.worldobesity.org/country/singapore-192/
5. Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93(3):351-359 2. CDC, Cancers Associated with Overweight and Obesity Makeup 40 percent of Cancers Diagnosed in the United States. Available at https://www.cdc.gov/media/releases/2017/p1003-vs-cancer-obesity.html.
6. World Health Organization. (2024). Obesity and overweight.WHO.https://www.who.int/news-room/factsheets/detail/obesity-and-overweight As accessed on 22nd May 2025.
7. Leu J, Rebello SA, Sargent GM, Kelly M, Banwell C. Hard work, long hours, and Singaporean young adults' health. A qualitative study. Frontiers in Public Health. 2023; 11. https://doi.org/10.3389/fpubh.2023.1082581
Hashtag: #NovoNordisk #Wegovy
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
a day ago
- The Star
Need for more psychologists
MALAYSIA is in dire need of psychologists. The shortage of mental health professionals has been exacerbated by post-Covid-19 issues such as anxiety and stress, as well as a rise in bullying linked to increased social media use. Describing the situation as 'dismal', Malaysian Mental Health Association president Prof Datuk Dr Andrew Mohanraj said the country, with a population of 35 million, only has 400 clinical psychologists. That is a ratio of one clinical psychologist for every 87,500 individuals. Prof Andrew 'Based on the World Health Organization (WHO) recommendation of one clinical psychologist for every 5,000 individuals, Malaysia is far short of the global benchmark,' he told StarEdu. Sunway University School of Psychology Prof Alvin Ng Lai Oon said the shortage means there are fewer opportunities for people to seek mental health services. The problem, however, is not a lack of interest in the career, stakeholders say. They assert that a new generation of psychology students wants to fill that gap, but outdated systems and unfair expectations are stumbling blocks that have caused many to reconsider their options. Tough road Interest in psychology is high among students – but channeling that interest into real careers is not easy, said public health researcher Ellern Eng Hui. He said the challenge starts with the lack of basic protection for those working in the field. 'Despite working to support the mental health of others, we ourselves often lack access to health benefits and job security. 'It's a difficult contradiction, and one that needs to be addressed.' The heavy costs involved are another deterrent. For students like Liong Kah Yan, who is currently pursuing her Master's in Applied Behaviour Analysis, the cost of studying psychology is steep – and the return is not immediate. 'Internship pays little, if at all. And when you finally find a job, the salary is usually low,' she shared, adding that a postgraduate degree is essential for a stable, better-paying role in clinical practice. She pointed out that pursuing a master's degree can cost RM60,000 or more, depending on the course. 'Not many people can afford it, as it is expensive even with scholarships,' she said. The path to becoming a clinical psychologist, said Prof Ng, is also extremely competitive. Prof Ng 'There are only 12 clinical psychology programmes in Malaysia. 'Even if students get in, the lack of qualified clinical supervisors and practicum agencies makes it tough to gain enough hands-on experience,' he noted. He added that trainees often struggle to secure placements for their required internships. 'In Malaysia, postgraduate clinical psychology trainees almost need to beg to be accepted as a clinical intern to receive supervised training, and there's no guarantee that they'll get the experience they need at a public health service if a supervisor is not available, or if psychological tools are not adequate.' This bottleneck, he explained, limits trainees' readiness for real-world practice and narrows their career options. Still considered a young profession, many experienced clinical instructors are under the age of 40 – leaving a gap in mentorship, he added. To make matters worse, Liong said psychology students also have to contend with unfair expectations because of their vocation. 'When I tell people that I study psychology, they would pour their whole life story and expect solutions from me. 'This is very unhealthy. Many psychology students are expected to give 'free' therapy to relatives, friends or just random people we know,' she said. Ellern said many people still do not realise that simply holding a bachelor's degree does not make someone qualified to diagnose mental health conditions. 'Diagnosis is a complex process that should only be done by licensed clinical psychologists. 'It involves detailed assessments, careful observations, and often multiple sessions,' he explained, stressing that it's not something one can figure out from a five-minute chat. Fixing the shortfall Malaysia needs to think beyond traditional methods to close the demand and supply gap for clinical psychologists, Prof Ng said. Calling for reforms to ensure rigorous clinical training and more structured career pathways, he said competitive salaries and clear progression routes are a must. 'Our salary scale is still under the S-job scheme, when there has long been a call to switch it to the U-job scheme, which offers a higher salary and clinical allowances,' he said. The U-salary scheme, Prof Ng explained, is meant for clinicians within the healthcare sector like medical doctors, pharmacists and dietitians. However, clinical psychologists are still categorised under the S-salary scheme, which is meant for social services roles like psychology officers, youth and sports officers, librarians and religious officers. 'The U-salary scheme basically acknowledges that the professional provides services within the clinical and health sector, which is what clinical psychologists are trained to do,' he added. The confusion happens, he said, because many people do not realise that clinical psychology focuses on treating patients, while other branches of psychology like organisational psychology, focus on different areas such as workplaces. Moreover, he highlighted a system he thinks Malaysia could learn from the United Kingdom's system – where psychology trainees are automatically employed within the National Health Service, ensuring on-the-job learning while contributing to healthcare services. Beyond placement and training, Prof Ng said equipping trainees with broader knowledge is equally important. 'I'd also like to see more involvement of medico-legal collaborations so that trainees are also savvy about legal issues and the laws of the land in guiding their clinical decision-making,' he added. Additionally, he suggested adopting a stepped-care model inspired by the UK's Improving Access to Psychological Therapies programme. Under this model, low-intensity therapists are trained in a shorter period – compared to traditional mental health professionals – to deliver basic psychological interventions. 'It's creating a new layer of professionals who are trained in low-intensity cognitive behaviour therapy that can be used to reduce symptoms of mental health conditions. They are also easier to access and cheaper than the usual mental health professionals,' he explained. On the other hand, Master's in Counselling student Tan Xin Yi, suggested implementing initiatives at the school level to draw more young Malaysians into the field. 'Schools can invite counsellors or clinical psychologists to share their experiences and show students what the work really looks like. 'It breaks down misconceptions and inspires students to see psychology as a meaningful career,' she said. Ellern agreed, as he said that psychology as a field is still relatively new here, having gained traction only in the last 50 to 60 years. 'Public awareness of mental health is still growing, and until it becomes more widespread and better understood, the demand for mental health services (and by extension, careers) will remain limited,' he explained. Without stronger awareness, Ellern said many people will not seek help, which in turn reduces opportunities for new graduates. 'That lack of demand then feeds into the struggle many psychology graduates face when trying to enter the job market,' he said.
Malaysian Reserve
2 days ago
- Malaysian Reserve
June in Review: 14 Top Health Press Releases
A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a landmark study in clinical cancer research and a new approach to increasing longevity. NEW YORK, July 11, 2025 /PRNewswire/ — With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and newsworthy trends, here's a recap of some of the past month's most read- and engaged-with stories. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketingIn support of transitioning patients from knock-off versions to authentic versions of Wegovy®, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk. Big4Bio and BYTE51 Announce Partnership at 2025 BIO International Convention to Make Life Sciences Intelligence Accessible to All BYTE51 provides powerful tools for exploring privately held biotech companies, allowing users to filter by scientific indications, mechanisms of action, funding stages, location, capital raised, clinical progress, investors, and partners. This empowers VCs, business developers, and startup executives alike to make faster, smarter, and more strategic decisions, all of which can benefit the diverse Big4Bio audience. Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk'VERVE-102 has the potential to be the first in vivo gene editing therapy for broad patient populations and could shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment,' said Ruth Gimeno, Lilly group vice president, Diabetes and Metabolic Research and Development. Mark Cuban Cost Plus Drug Company, PBC and 9amHealth Join Forces to Expand Access to Affordable Obesity Care Employees will now have access to low-cost, high-quality medications through Cost Plus Drugs, alongside 9amHealth's expert Care Team of Obesity Medicine physicians, endocrinologists, and cardiometabolic specialists—all available without long waits or costly appointments. Klotho Neuroscience, Inc. Announces an Approach To Increase Longevity and Healthy Life Span – Replace a Silenced Gene Called Alpha-Klotho ('α- KLOTHO') Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the human gene called Klotho. AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology 'By advancing CPTX2309 and utilizing Capstan's novel platform technology, AbbVie and Capstan aim to transform the care of those living with autoimmune diseases by developing treatments that have the potential to reset the immune system,' said Roopal Thakkar, M.D., executive vice president, research and development and chief scientific officer, AbbVie. Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence 'For too long, patients have had to weigh the benefits of SNM therapy against real concerns about complications related to implanted batteries and the need for surgeries to replace it. Neuspera's integrated system provides symptom relief without these additional burdens,' said Dr. Howard Goldman, vice-chairman of Urology at the Cleveland Clinic. Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies Shasqi's Click Activated Protodrugs Against Cancer (CAPAC®) platform is a pre-targeting technology composed of a tumor binding agent and a protodrug. Administered sequentially, these components are designed to only click with each other via a click chemistry reaction occurring directly at the tumor site. This releases high concentrations of cancer drugs at the tumor while sparing healthy tissues. Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput next-generation-sequencing (NGS) platforms. Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ The Processor is the first in bone conduction to enable Bluetooth® LE Audio* and Auracast™ broadcast audio streaming capabilities. As more venues adopt Auracast technology, Baha 7 Sound Processor recipients can access audio streams in places like theaters, concert halls, lecture halls and airports, through an LE Audio-enabled smartphone. Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal 'With Olink® Reveal offering deep insights into inflammatory biology, we empower researchers to accelerate biomarker discovery, translational research, and precision medicine. This recognition further enhances Novogene's leadership in comprehensive multi-omics solutions,' said Justin Lee, Novogene VP of Global Marketing. Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea Mosanna is pioneering a pharmaceutical solution for sleep apnea patients with MOS118, a nasal spray administered at bedtime that helps restore the body's natural airway reflex. Research has shown that, for reasons yet unknown, the natural airway reflex in OSA patients exhibits decreased activity during sleep resulting in loss of airway patency and apnea. Grady Launches Emergency Medical Helicopter in Partnership with Air Methods This cutting-edge air ambulance will be staffed entirely by Grady medical personnel – highly trained nurses, paramedics, and critical care specialists – while experienced pilots from Air Methods will operate the aircraft. The partnership brings together top-tier medical care and aviation expertise to deliver life-saving interventions to patients faster than ever before. Visby Medical™ Raises up to $65 Million in New Financing Round to Accelerate Launch of Groundbreaking At-Home Sexually Transmitted Infections (STI) Test 'Visby Medical has delivered the first and only laboratory-grade STI testing solution that can be made directly accessible to individuals. We were eager to invest in Visby ahead of their FDA clearance, knowing this would represent a breakthrough moment for the diagnostics industry,' said Isaac Ro, Catalio Capital Management Partner. For more news like this, check out all of the latest health-related releases from PR Newswire. Trending Topics Among the health news that was distributed in June, the PR Newswire team was able spot several larger stories that highlight the trends shaping the industry. Men's Mental Health: Men's Mental Health Month aims to break the stigma and explore the factors that play into to the often less talked about issue. Studies released in June point looked into several contributing factors. According to Postpartum Support International, at least one in ten fathers experience postpartum depression during the perinatal period with as many as 50% of fathers suffering at the same time as their partners. On the financial side of things, Beyond Finance revealed financial distress is fueling a silent mental health crisis among men, driven by secrecy, shame and isolation. Men have reported feeling frustrated, anxious, overwhelmed and embarrassed because of their financial situation — yet nearly a quarter (22%) don't feel comfortable seeking out financial advice from anyone. Sleep Health: The Associated Professional Sleep Societies (APSS) hosted its annual meeting, SLEEP 2025, in Seattle from June 8-11. The event showcased several advances shaping the future of sleep medicine. Researchers from Huxley Medical shared data highlighting the capabilities of the SANSA home sleep apnea test. Another study, this one from Rest and SleepScore Labs, showed significant perceived improvements in sleep comfort, temperature regulation and overall sleep quality when using Rest's Evercool® products like pillowcases and sheets. Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at
The Sun
2 days ago
- The Sun
Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
SINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious chronic diseases, has announced the availability of Wegovy® (semaglutide 2.4mg) in Singapore. Wegovy® (semaglutide 2.4mg) is a once-weekly injectable treatment indicated for chronic weight management in adults and adolescents (aged 12 and above) living with obesity (BMI ≥30 kg/m²), or who are overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia1. It is used alongside a reduced-calorie diet and increased physical activity, supporting Singapore's efforts to improve population health. The treatment works by addressing one of the underlying biological drivers of obesity. Wegovy® (semaglutide 2.4mg) is a GLP-1 receptor agonist with 94% similarity to the body's natural GLP-1 hormone. It activates receptors involved in appetite regulation, helping individuals feel full sooner and reduce food intake1. This mechanism supports weight loss when combined with sustainable lifestyle changes. The availability of Wegovy® (semaglutide 2.4mg) comes as obesity continues to pose a significant health burden in Singapore. An estimated 600,000 adults are currently living with obesity2-4, a condition associated with more than 200 health complications5. Despite its prevalence and medical complexity, obesity remains heavily stigmatised—often misunderstood as merely the result of poor personal choices. Individuals living with obesity frequently face discrimination and mental health challenges which further isolate them. This misplaced blame, rather than targeting the disease itself, creates barriers to and slows the advancement of effective obesity treatment. Recognised by World Health Organization as a chronic disease6, obesity requires compassionate evidence-based care. The launch of Wegovy® (semaglutide 2.4mg) in Singapore provides a new treatment option for weight management available through private prescription. Dr Abel Soh, Abel Soh Diabetes, Thyroid and Endocrine Clinic and Chairperson for Endocrine and Metabolic Society of Singapore (EMSS) stated, 'Obesity is not simply the result of lifestyle choices — it is a medically recognised chronic disease influenced by a complex interplay of genetics, hormones, and environment. In my clinical practice, I see firsthand how many individuals blame themselves when in fact, their biology is often working against them. It's time we shift the conversation from blame to support in the management of individuals with obesity' Lifestyle factors in Singapore further contribute to the challenge. In Singapore's demanding work culture—where full-time employees work an average of 44.6 hours per week7, with time constraints and fatigue frequently cited as barriers to maintaining regular physical activity. These circumstances underscore the importance of comprehensive treatment strategies that facilitate the adoption of healthier lifestyles, including increased physical activity and a reduced-calorie diet, as integral components of long-term weight management. Mr Vincent Siow, General Manager, Novo Nordisk Singapore, said 'With treatments like Wegovy® (semaglutide 2.4mg) now available in Singapore, we have an opportunity to provide healthcare professionals with more evidence-based options to support their patients in regaining control of their health and improving long-term outcomes.' References: 1. Wegovy Singapore Prescribing Information, February 2025 2. Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508. 3. World Obesity. Retrieved from 4. World Obesity. Retrieved from 5. Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93(3):351-359 2. CDC, Cancers Associated with Overweight and Obesity Makeup 40 percent of Cancers Diagnosed in the United States. Available at 6. World Health Organization. (2024). Obesity and As accessed on 22nd May 2025. 7. Leu J, Rebello SA, Sargent GM, Kelly M, Banwell C. Hard work, long hours, and Singaporean young adults' health. A qualitative study. Frontiers in Public Health. 2023; 11. Hashtag: #NovoNordisk #Wegovy The issuer is solely responsible for the content of this announcement.
